2021
DOI: 10.1186/s12885-021-08868-4
|View full text |Cite
|
Sign up to set email alerts
|

Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC

Abstract: Objectives Forkhead box D1, the core transcription factor member of FOX family, has gradually seen as a key cancerous regulatory. However, its expression and carcinogenicity in head and neck squamous cell carcinoma (HNSCC) have not been reported yet. This study was to investigate its expression pattern, clinicopathological significance and biological roles in HNSCC. Methods HNSCC data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 30 publications
0
6
0
Order By: Relevance
“…The signaling of FGF10 and the expression of Wnt5a and Foxd1 were blocked in culture with the FGFR inhibitor (Infigratinib at 1uM as in Manchado et al, 2016; Nakamura et al, 2015; Wong et al, 2018), siWnt5a (at 20nM as in Nemoto et al, 2012; Sakisaka et al, 2015; Zhao et al, 2017) and siFoxd1 (at 20nM as in Li et al, 2021; Nakayama et al, 2015; Wu et al, 2018) respectively, and their effects on other SCMF genes were quantified by RT-PCR (Fig.4C). Identified genes with significant change are designated as targets of the gene/pathway perturbed, and their connections are plotted on the network (Fig.4D).…”
Section: Resultsmentioning
confidence: 99%
“…The signaling of FGF10 and the expression of Wnt5a and Foxd1 were blocked in culture with the FGFR inhibitor (Infigratinib at 1uM as in Manchado et al, 2016; Nakamura et al, 2015; Wong et al, 2018), siWnt5a (at 20nM as in Nemoto et al, 2012; Sakisaka et al, 2015; Zhao et al, 2017) and siFoxd1 (at 20nM as in Li et al, 2021; Nakayama et al, 2015; Wu et al, 2018) respectively, and their effects on other SCMF genes were quantified by RT-PCR (Fig.4C). Identified genes with significant change are designated as targets of the gene/pathway perturbed, and their connections are plotted on the network (Fig.4D).…”
Section: Resultsmentioning
confidence: 99%
“…The signaling of FGF10 and the expression of Wnt5a and Foxd1 were blocked in culture with the FGFR inhibitor (Infigratinib at 1 uM as in Manchado et al, 2016 ; Nakamura et al, 2015 ; Wong et al, 2018 ), siWnt5a (at 20 nM as in Nemoto et al, 2012 ; Sakisaka et al, 2015 ; Zhao et al, 2017 ), and siFoxd1 (at 20 nM as in Li et al, 2021 ; Nakayama et al, 2015 ; Wu et al, 2018 ), respectively, and their effects on other SCMF genes were quantified by RT-PCR ( Figure 4C ). Identified genes with significant change are designated as targets of the gene/pathway perturbed, and their connections are plotted on the network ( Figure 4D ).…”
Section: Resultsmentioning
confidence: 99%
“…This phenomenon is consistent with previous studies. Huang et al and Li et al found that FOXD1 was highly expressed in carcinoma tissues, and this high expression turned out to be the independent prognostic factors that had a significant relationship with the survival of patients [ 28 , 29 ]. Different from what Li et al had demonstrated [ 30 ], we noted that the expression of FOXD1 was not statistically related to advanced TNM stage and N+ status, but a high expression of FOXD1 was correlated with recurrence or metastasis.…”
Section: Discussionmentioning
confidence: 99%